Lucas AM - Search Results

1

Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes.

Alonso N, Granada ML, Salinas I, Lucas AM, Reverter JL, Juncà J, Oriol A, Sanmartí A. Alonso N, et al. Among authors: lucas am. J Clin Endocrinol Metab. 2005 Sep;90(9):5254-8. doi: 10.1210/jc.2005-0580. Epub 2005 Jul 19. J Clin Endocrinol Metab. 2005. PMID: 16030155

2

Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?

Lucas A, Salinas I, Rius F, Pizarro E, Granada ML, Foz M, Sanmartí A. Lucas A, et al. J Clin Endocrinol Metab. 1997 Aug;82(8):2410-3. doi: 10.1210/jcem.82.8.4118. J Clin Endocrinol Metab. 1997. PMID: 9253309 Clinical Trial.

3

Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?

Lucas A, Pizarro E, Granada ML, Salinas I, Sanmartí A. Lucas A, et al. Clin Endocrinol (Oxf). 2001 Dec;55(6):809-14. doi: 10.1046/j.1365-2265.2001.01421.x. Clin Endocrinol (Oxf). 2001. PMID: 11895224

4

Suppressive therapy with levothyroxine for solitary thyroid nodules.

Reverter JL, Lucas A, Salinas I, Audí L, Foz M, Sanmartí A. Reverter JL, et al. Clin Endocrinol (Oxf). 1992 Jan;36(1):25-8. doi: 10.1111/j.1365-2265.1992.tb02898.x. Clin Endocrinol (Oxf). 1992. PMID: 1559296 Clinical Trial.

5

Fine-needle aspiration cytology of benign nodular thyroid disease. Value of re-aspiration.

Lucas A, Llatjós M, Salinas I, Reverter J, Pizarro E, Sanmartí A. Lucas A, et al. Eur J Endocrinol. 1995 Jun;132(6):677-80. doi: 10.1530/eje.0.1320677. Eur J Endocrinol. 1995. PMID: 7788005 Clinical Trial.

6

Lipoprotein composition in the insulin-deficient non-acidotic phase of type I diabetic patients and early evolution after the start of insulin therapy.

Reverter JL, Sentí M, Rubiés-Prat J, Lucas A, Salinas I, Pizarro E, Pedro-Botet J, Sanmartí A. Reverter JL, et al. Clin Chim Acta. 1993 Dec 31;223(1-2):113-20. doi: 10.1016/0009-8981(93)90067-e. Clin Chim Acta. 1993. PMID: 8143357

7

Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population.

Granada ML, Murillo J, Lucas A, Salinas I, Llopis MA, Castells I, Foz M, Sanmartí A. Granada ML, et al. Eur J Endocrinol. 2000 Mar;142(3):243-53. doi: 10.1530/eje.0.1420243. Eur J Endocrinol. 2000. PMID: 10700718

8

Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.

Alonso N, Granada ML, Lucas A, Salinas I, Reverter J, Oriol A, Sanmarti A. Alonso N, et al. J Endocrinol Invest. 2004 May;27(5):449-54. doi: 10.1007/BF03345290. J Endocrinol Invest. 2004. PMID: 15279078 Clinical Trial.

9

Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients.

Romero R, Salinas I, Lucas A, Teixidó J, Audi L, Sanmarti A. Romero R, et al. Diabetes Res Clin Pract. 1992 Sep;17(3):191-8. doi: 10.1016/0168-8227(92)90094-8. Diabetes Res Clin Pract. 1992. PMID: 1425158 Clinical Trial.

10

Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.

Romero R, Salinas I, Teixidó J, Lucas A, Felip A, Sanmarti A. Romero R, et al. J Hum Hypertens. 1990 Dec;4(6):671-5. J Hum Hypertens. 1990. PMID: 2096209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters